Stockscreener 앱 받기
6.27
1.26%
-0.09
Cingulate Inc 주식(CING)의 최신 뉴스
[EFFECT] Cingulate Inc. SEC Fi... | CING SEC FilingForm EFFECT - Stock Titan
Can Cingulate Inc Equity Warrant sustain earnings growthWeekly Trade Review & Trade Opportunity Analysis - baoquankhu1.vn
Cingulate Inc. Enters ATM Sales Agreement with A.G.P./Alliance Global Partners for Common Stock Offering – March 2026 - Minichart
Cingulate Announces ATM Equity Program and Share Issuance - TipRanks
Cingulate Inc has submitted a prospectus supplement to the U.S. Securities and Exchange Commission, planning to conduct a market offering and sell common shares in phases for a total amount of up to 100 million dollars. - Bitget
Cingulate (NASDAQ: CING) adds $100M ATM share sale capacity - Stock Titan
Cingulate Inc. (NASDAQ: CING) launches up to $100M ATM sales program - Stock Titan
Cingulate’s ADHD Drug Is Near An FDA Verdict - Finimize
Roth Capital Lowers Price Target for Cingulate (CING) to $14, Ma - GuruFocus
Roth Mkm Cuts Cingulate (NASDAQ:CING) Price Target to $14.00 - MarketBeat
Cingulate (NASDAQ: CING) files S-3/A amendment adding KPMG consent - Stock Titan
If You Invested $1,000 in Cingulate Inc (CING) - Stock Titan
History Review: Is Cingulate Inc likely to announce a buyback2026 Fundamental Recap & Low Volatility Stock Recommendations - baoquankhu1.vn
Cingulate Stock Snaps 2-Day Losing Streak As Roth Hikes Target On ADHD Drug Review; Retail Bets On Buyout Potential - MSN
What's going on with Cingulate stock today? - MSN
Cingulate stock jumps overnight: US Patent Office clears ADHD drug filing ahead of May FDA catalyst - MSN
Stock Report: How cyclical is Cingulate Inc Equity Warrants revenue stream2026 Valuation Update & Long Hold Capital Preservation Plans - baoquankhu1.vn
CING: Laying the Foundation for 1H:27 Launch - Research Tree
What's Going On With Cingulate Stock Today? - Benzinga
3.5M-share resale registration by Cingulate (NASDAQ: CING) under Lincoln Park deal - Stock Titan
Cingulate (NASDAQ:CING) Releases Quarterly Earnings Results, Misses Estimates By $0.28 EPS - MarketBeat
Cingulate (CING) Expected to Announce Earnings on Thursday - MarketBeat
Cingulate Reports 2025 Financial Results, Advances CTx-1301 ADHD Drug with New Patents and NDA Progress - Minichart
Cingulate Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Cingulate Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights - Bitget
Why Is CING Stock Jumping Over 4% In Overnight Trading? - Stocktwits
Cingulate Inc. Advances Precision Timed Release ADHD and Anxiety Treatments with Innovative Drug Delivery Platform – 2025 Annual Report Highlights - Minichart
Cingulate (CING) outlines CTx-1301 FDA review, ADHD market and PTR pipeline - Stock Titan
Cingulate 10-K: $0 Revenue, $(22.45)M Net Loss - TradingView
PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention - Benzinga
CING: 2025 net loss widened to $22.4M as CTx-1301 advanced toward FDA review and $12M was raised - TradingView
CING: NDA for CTx-1301 accepted, $12M raised, and cash runway extends into late Q4 2026 - TradingView
CING: 2025 net loss widened to $22.4M; cash runway into late 2026, pending CTx-1301 FDA approval - TradingView
Patent wins and $12M PIPE support Cingulate (NASDAQ: CING) - Stock Titan
Cingulate Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Gains Report: How is Cingulate Inc managing supply chain issues2026 Macro Moves & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
Why did Cingulate stock skyrocket today? - CryptoRank
Cingulate Stock Jumps Overnight: US Patent Office Clears ADHD Drug Filing Ahead Of May FDA Catalyst - Asianet Newsable
Cingulate (CING) CEO gets 6,862-share bonus grant, 2,959 withheld for tax - Stock Titan
Cingulate (CING) EVP awarded 4,526 shares; 1,828 withheld for taxes - Stock Titan
Cingulate (CING) EVP Brams receives stock grant with tax withholding - Stock Titan
Cingulate (NASDAQ:CING) Trading Up 6.5%Here's What Happened - MarketBeat
How strong is Cingulate Inc. stock revenue growthPortfolio Gains Summary & Risk Controlled Stock Alerts - Naître et grandir
EPS Watch: Is Cingulate Inc currently under institutional pressureMarket Movers & Low Risk Growth Stock Ideas - baoquankhu1.vn
Fundamentals Check: Is Cingulate Inc likely to announce a buybackJuly 2025 Reactions & Consistent Growth Equity Picks - baoquankhu1.vn
Retail Trends: How cyclical is Cingulate Inc Equity Warrants revenue streamTrade Risk Report & Expert Verified Movement Alerts - baoquankhu1.vn
Can Cingulate Inc. stock rebound after recent weaknessNew Guidance & Free Technical Confirmation Trade Alerts - Naître et grandir
CING|Cingulate Inc|Price:6.430|Chg%:-0.13 - TradingKey
Cingulate (NASDAQ: CING) vote on 19% share issuance and warrants - Stock Titan
Pullback Watch: Is Cingulate Inc Equity Warrant a turnaround storyJuly 2025 Catalysts & Long-Term Growth Plans - baoquankhu1.vn
Risk Hedge: Can Cingulate Inc Equity Warrant maintain its current growth ratePrice Action & Daily Volume Surge Signals - baoquankhu1.vn
CING Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Aug Highlights: Can Cingulate Inc disrupt its industryDividend Hike & Daily Growth Stock Investment Tips - baoquankhu1.vn
CINGW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Buybacks Report: Does COLAR meet Warren Buffetts criteria2025 Growth vs Value & Accurate Buy Signal Notifications - baoquankhu1.vn
Can Cingulate Inc. Equity Warrant maintain its current growth rate - mfd.ru
What drives Cingulate Inc.’s stock priceJuly 2025 Trade Ideas & Consistent Growth Equity Picks - mfd.ru
Investment deal brings well-known area entrepreneur to Cingulate board - The Business Journals
0.99%
3.03%
자본화:
|
볼륨(24시간):